Bio-Gene Technology Limited (ASX:BGT) Secures US DoD Grants for Insecticide Development
Grant Awards
Bio-Gene Technology Limited has been awarded A$3.0 million by the U.S. Department of Defense for the Deployed Warfighter Protection (DWFP) program. The grants support the development of wearable products containing Flavocide® and Qcide®, aimed at protecting military personnel from disease-carrying insects.
Insecticide Development
The company is in late-stage development of Flavocide® and Qcide®, two insecticidal compounds derived from a unique subtype of eucalypt. These products offer novel modes of action and are effective against pests resistant to standard treatments, meeting the growing demand for safer, environmentally friendly solutions.
Strategic Partnerships
Bio-Gene has established partnerships with Clarke Mosquito Control in the US, Evergreen Garden Care across the EU, UK, AU & NZ, and STK Bio-Ag in Israel. These collaborations support the company’s strategy to target professional pest management, home garden, and crop protection markets.
Quarterly Updates
In Q2 FY25, Bio-Gene advanced the production of Qcide® oil and initiated GLP safety studies for Flavocide®. The company also expanded seed production and continued to strengthen its pipeline with eight formulated product opportunities across various sectors, including public health and crop protection.
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.